Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STC007 injection for moderate postoperative abdominal pain
CTR20254440Phase 3Active
- Sponsor
- Chengdu Nuoshengtai Biotechnology
- Start
- Nov 2025
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine liposome in postoperative pain, sponsored by Chengdu Nuoshengtai Biotechnology. Started Nov 2025; status: active.
02
Drugs
bupivacaine liposome
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20254440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254440.